VC Fund Dossiers

Big Pi is the real deal in the Greek/diaspora space - they're not just tourist money but serious operators with legit exits under their belt (Accusonus to Meta for €70-100M). The team brings actual entrepreneurial chops: Marco built Upstream to €230M revenue, Nick was at Prime Ventures doing serious European deals, and Alex literally helped create the Python data science stack. They require portfolio companies to maintain substantial Greek operations, which is both a feature (cheap talent, government support) and potential bug (geographic constraint). Their "tech-first" mandate with IP requirements means they actually understand what defensible tech looks like, unlike funds that chase flashy B2C plays.

It's dubbed this approach 'high conviction investing'. 'Our philosophy is that we only succeed if the team succeeds; we're in it together,' she adds. Blossom walks the walk on founder support — they genuinely limit themselves to 5-6 deals per year so they can be ridiculously helpful. Unlike a typical lead Series A investor, Blossom generally doesn't take a board seat — it sits on boards for just two of its eight portfolio companies. Instead, Blossom builds dashboards with its portfolio companies, so that the team has live access to tracking metrics and data on the startups. They've cracked the code on being a true partner without being overbearing. The team has serious technical chops (Imran) plus strong US connections (Alex from IVP), and Ophelia's reputation for responsiveness is legendary. Their track record speaks volumes — Blossom Capital has a portfolio of 44 companies, including 6 unicorns. They're expensive (large Series A checks) but if you want a VC who genuinely rolls up sleeves and opens doors globally, they deliver.

BlueYard is what happens when former Earlybird partners decide to bet the farm on civilization ending or reaching utopia - and somehow nail the timing on both fronts. Their first fund's 76% gross IRR and 3.4x DPI speaks for itself, driven by getting into crypto in 2016, AI chips in 2018, and defense tech in 2023 when everyone else thought these spaces were radioactive. They're genuinely 'fluent in weirdness and volatility' - this isn't marketing speak. If you've been told you're 'too early, not big enough, or not in their category,' they literally want you to call them. The partners actually do deep technical diligence and aren't afraid to lead rounds in spaces that make other VCs uncomfortable. Fair warning: they're genuinely contrarian, so if you're building something obvious or looking for validation, this isn't your fund.

bmp Ventures is one of Germany's old guard VC firms with genuine track record - 25 years of venture capital experience, 11 funds, over 250 investments, 120 exits and more than 15 IPOs. That's not fluff, that's real dealflow. The Komoot exit to Bending Spoons in March 2025 was solid, and they've had other decent wins like Flightright. What's interesting is their heavy focus on cleantech/materials science - they're not chasing the latest AI hype but betting on industrial deep tech that actually solves problems. The fact that they manage government funds (Saxony-Anhalt) gives them patient capital but also bureaucratic constraints. Their average holding period is around 6 years - significantly longer for certain technologies, which is refreshing in a world of quick-flip VCs. Oliver Borrmann's been at this since 1997 and actually knows how to build companies, not just write checks.

They've delivered 20%+ annual returns since 2014 with portfolio value exceeding SEK 7B, but here's the reality: they rebranded from Bonnier Ventures to Bonnier Capital to signal they're moving upmarket to bigger, later-stage deals. The 'we're different because we're not a fund' pitch is real - they have patient capital from the 200-year-old Bonnier media empire. They lead fewer deals than average but exit more often, suggesting they're selective but effective. The Bonnier Group network can genuinely open doors, especially in media and Nordic markets. However, team is only 6 people for a portfolio this size, so don't expect hand-holding.

BonVenture is Germany's OG impact fund - they've been doing this since before 'impact' was trendy, which gives them serious street cred and deep networks. They're the first German fund officially EuSEF-registered and manage around €100M across multiple funds with 60+ impact investments. The team is 50% female and 2/3 female at partner level, which actually matters for deal flow and founder rapport. What's refreshing is they don't just ESG-wash - they actually measure impact with their own methodology. The downside? They're pretty rigid about their impact thesis, so if you're not solving a clear social/environmental problem with measurable outcomes, don't bother. Also, being Munich-based means they're not as plugged into Berlin's startup scene, though that's changing.

This is France's sovereign wealth fund playing VC - which means they have deeper pockets and longer patience than most, but also means they're not purely profit-driven. They offer unique convertible options that match private investment up to €250k with non-dilutive support, which founders love because it makes them more attractive to other investors. Their strategy is explicitly to create an 'entrepreneur friendly ecosystem' and develop France's VC industry to attract international money. The downside? Some French tech veterans like Ledger's co-founder argue that state backing has propped up fragile business models and created a 'perfusion economy' that masks underlying weaknesses. But founders consistently praise their operational involvement, strategic introductions, and commercial synergies that lead to 'decisive contracts.'

Breega is solid but not spectacular - they're the reliable European fund that won't wow you but probably won't disappoint either. Ben Marrel genuinely knows how to scale companies having done it himself, and they're actually helpful post-investment unlike some VCs who just show up to board meetings. The downside? They can be slow decision makers and their network outside Europe is limited. They also have a habit of leading rounds then getting diluted in later stages when bigger funds come in. Good for founders who want steady, experienced guidance and don't need flashy brand names on their cap table.

Bright Pixel is basically Sonae's corporate venture arm with €250M deployed across 60+ companies, which sounds impressive until you realize they're essentially a retail conglomerate trying to stay relevant in tech. The good news: they have four unicorns including Feedzai and Arctic Wolf, proving they can spot winners. The reality check: as a corporate VC, they're always going to prioritize strategic value over pure financial returns, which means potential acqui-hire pressure down the road. Their team seems genuinely knowledgeable about cybersecurity and retail tech, but founders should expect longer decision cycles and more stakeholder management than with pure-play VCs.

BrightCap has already delivered 4-5 exits from their €25M Fund I, with portfolio companies raising $60M+ in follow-ons and reaching $600M+ enterprise value. Their biggest bet LucidLink has raised $115M total and could alone return their entire first fund. Fund II is one of the very few VCs with female majority among General Partners. They source 60% of deals through proprietary networks rather than waiting for inbound - they actively hunt. The 'global founders, local engineers' thesis is smart arbitrage: Western market access with Eastern European engineering talent costs. They're hands-on with diverse skill sets helping with product validation, talent recruitment, fundraising, and emotional support. But founders should know they need Bulgarian/Romanian engineering presence for public fund compliance.

These are the MOOR veterans who actually know how to build companies, not just write checks. John Elvesjö isn't some MBA who read about startups - he built Tobii from university research to a billion-dollar public company over 17 years. The team's MOOR track record (Acast, Volumental, FirstVet) shows they can spot winners early and stick with them. They're genuinely hands-on operators who will roll up their sleeves on product and business development. The downside? They're picky as hell and move deliberately - this isn't a spray-and-pray fund. Also note they haven't been super active lately, which could mean fund lifecycle issues or just being selective.

These guys are the rare VC fund that actually gets hardware and deep tech - not just buzzword deep tech, but real industrial engineering problems. According to their internal data, hardware and deep tech companies perform best because they focus on revenue early and have protectable IP almost right away. What's refreshing is they're hands-on without being micromanaging control freaks - they join each investment in 'sales and business development' sprints for a few weeks of heavy focus followed by reassessment. The founding partners complement each other well: Risku knows product-market fit from the operator side, Kanninen handles the complex deal structuring, and they're genuinely helpful post-investment rather than just board meeting attendees. The downside? They're geographically focused on the Nordics, so if you're not Finnish/Swedish or willing to relocate there, you're probably not on their radar.

Bvalue is solid if you're a CEE founder or want access to that market, but they're not going to wow Silicon Valley with their network. They actually know their region well and have produced some legitimate exits, which puts them ahead of most regional European funds. The partners are former operators who get their hands dirty, but don't expect them to open doors in SF or lead your Series B. They're best as a local champion who can help you navigate Polish/CEE expansion and provide tactical support. The fund size means they can't write big checks, so plan accordingly for future rounds.

byFounders is exactly what it sounds like - actual operators who've been through the founder journey and genuinely get the operational challenges. They're particularly strong on European expansion and B2B go-to-market, but don't expect them to write big checks or lead Silicon Valley-style mega rounds. They're hands-on without being overbearing, and their portfolio companies consistently praise their practical advice over theoretical frameworks. The downside? They can be pretty conservative on valuations and might push for profitability metrics earlier than other funds.

Bynd claims a fast 2-4 week process which is genuinely founder-friendly if true. With 15+ years investing and 10+ exits from 60+ investments, they have real track record - not just marketing fluff. Portfolio founders genuinely seem happy: 'extremely active partners helping and advising us on important decisions' and 'strategic asset for start-ups like us.' Their platform of 400+ connections and 70+ active founders suggests real value-add beyond just capital. The Iberian focus is narrow but smart - they know their market and have genuine local network effects. Co-investing frequently with Portugal Ventures shows they're plugged into the ecosystem. Only red flag: claiming 60+ investments but only 10+ exits after 15 years suggests either very early vintage or modest outcomes.

This is Spain's establishment VC - they're the corporate venture arm of CriteriaCaixa, which manages over €25 billion and is backed by la Caixa Foundation. They've been around since 2007 and have made 300+ investments, so they know what they're doing, but they're also exactly what you'd expect from a big Spanish bank's VC arm. The good news: they have serious capital staying power, they actually stick around for follow-on rounds, and they exit 20% more often than average. The reality check: they're not exactly known for being the fastest movers or most founder-friendly when it comes to terms. New CEO Jordi Ros comes from 20 years of traditional corporate finance, not startup-land.

According to Sifted data, Calm/Storm is the most active specialist healthtech VC in Europe. Polagnoli says the firm saw 92% of all Europe's public pre-seed digital health rounds between July and September. This isn't marketing fluff – they're genuinely everywhere in European healthtech. Named #1 HealthTech investor in Europe since 2020, but here's the thing: they're obsessed with taboo topics like sexual wellness, fertility, and mental health – areas other VCs won't touch. What sets Calm/Storm apart is its intimate, founder-focused style. Created by founders for founders, it fosters a close-knit network. Lucanus acts more like a co-founder than a typical VC, which can be amazing or suffocating depending on your style. They're genuinely helpful but expect serious commitment to their community-first approach.

CIC has genuinely unique deal flow through their exclusive Cambridge University relationship - this isn't marketing fluff, they literally have privileged access to the best IP coming out of one of the world's top research universities. Their track record speaks for itself: Bicycle Therapeutics IPO on NASDAQ, CMR Surgical unicorn, Gyroscope sold to Novartis for $1.5B, plus solid exits like Inivata ($390M) and PetMedix ($285M). Williamson brings serious credibility - 20 years US VC experience and co-chaired the UK government's university spinout review, so he knows the ecosystem inside out. Their Entrepreneur in Residence program is actually working - they're co-founding companies like Immutrin (just raised £65M from Frazier Life Sciences) by pairing seasoned operators with Cambridge academics. The downside? You're essentially betting on Cambridge staying relevant in deep tech, and they're very UK-focused if you want Silicon Valley-style growth.

CapHorn got acquired by Anaxago in 2022, which means they're now part of a crowdfunding platform empire rather than a pure VC. They've got one unicorn (Ledger) and decent exits, but let's be real - this is a solid mid-tier French fund, not the next Sequoia. They talk up their conviction plays like Worldia, which survived COVID, but that's table stakes for any decent VC. With 14 team members and no board seats, they're more financial investors than hands-on partners. The Anaxago integration could be a plus for deal flow and follow-on capital, or it could mean more bureaucracy and less focus. The proof will be in Fund 3 performance.

Capnamic is the German VC equivalent of that reliable friend who shows up with tools when you're moving apartments. They're genuinely founder-friendly without the Silicon Valley theatrics - the 'Bullshit Buzzer' in their conference room tells you everything about their no-nonsense approach. Christian Siegele's 3i pedigree shows in their disciplined deal process, and they actually follow through on follow-on funding commitments (novel concept, right?). The track record speaks for itself: LeanIX to SAP, Adjust to AppLovin, Staffbase hitting unicorn status. They're particularly strong in DACH B2B software where their corporate LP network creates real value for portfolio companies. The downside? They're very focused on the German-speaking market, so if you're not planning to build there or serve that market, look elsewhere.

Capricorn is the rare European VC that actually walks the walk on deep tech and sustainability—they've been doing cleantech since 2007, way before it was cool again. With 2 unicorns (Electric Hydrogen and Xanadu) in their portfolio and a track record spanning 26 years, they're not just another generalist fund pretending to understand hard science. Jos Peeters is a proper physics PhD who's been in the game for over three decades and built the European VC infrastructure we know today. The team genuinely gets technical due diligence, but here's the catch: they're very Belgian in their approach—methodical, relationship-focused, and not flashy. They invest mostly in Belgium (28 companies) and Netherlands (9 companies), so if you're not in their geographic sweet spot or willing to relocate there, you might find yourself on the outside looking in.

This is classic old-school UK venture capital - the kind that's been around since 1999 and has the battle scars to prove it. They've delivered solid returns with 14 profitable exits since 2015 averaging 4.7x, including some standout wins like R2C Online at 12.6x and Accutronics at 9.1x. What's refreshing is they actually take board seats and get their hands dirty - each partner has direct portfolio responsibility and they're not afraid to help with hiring, customer introductions, and financial strategy. With £130m under management, they're mid-sized but experienced. The downside? They're a small team (2-10 employees) which means limited bandwidth, and their heavy life sciences focus means if you're not in healthcare/biotech, you're probably not their cup of tea. They seem genuinely committed to long-term value creation rather than quick flips, which is either exactly what you want or frustratingly slow depending on your timeline.

CDP is Italy's €4 billion sovereign wealth fund playing venture capitalist - which means you get the benefits of patient capital and government backing, but also all the bureaucracy that comes with it. They have an initial €1 billion to deploy and are making 40-50 investments per year, so they're not exactly selective. The real power here is Francesca Bria - she's the rare government appointee who actually gets technology and has street cred from transforming Barcelona's smart city approach. Under Resmini they grew from €230M to €4B AUM in 3 years, which is impressive scaling but raises questions about quality control. They're essentially the Italian government's attempt to bootstrap a venture ecosystem, so expect slower decision-making but also less pressure for quick exits since they're playing the long game for Italy's economic development.

Chalmers Ventures is the real deal for deeptech - they're not just investors throwing money around, they're basically the commercialization arm of one of Europe's top tech universities. Ranked as one of the world's top ten university-based venture builders, launching around ten new startups annually. The Google acquisition of Atlantic Quantum is proof they can get deeptech from lab to billion-dollar exits. What makes them different is the evergreen structure - they're not under pressure to return capital to LPs in 7-10 years, so they can actually wait for deeptech timelines. Pontus Ottosson has serious operational chops from his previous CEO role, not just investment experience. The downside? They're very focused on Chalmers ecosystem companies, so if you're not connected to the university, you're probably not getting a look.

Change Ventures is the real deal - probably the most founder-friendly fund in the Baltics with genuine operational chops. They ranked among Europe's top 10 VCs by founder reviews on Landscape, based on speed, responsiveness and value-add, which is rare for a regional fund. The partners aren't just check-writers; they've actually built and exited companies themselves. Andris has two $100M+ exits, the Ojasaar brothers literally created Estonia's VC ecosystem, and founders consistently praise their hands-on support: 'We've not only received full support, but Change Ventures provided the right hands-on at the right time, even unasked. Could not wish for better investors for the stage we're in.' They move fast, give clear feedback even when passing, and have a unicorn (Veriff) plus a solid exit (Nordigen to GoCardless) to show for it.

Cherry Ventures is one of the more competent European early-stage funds that actually gets operational stuff right. They're not just check-writers - they have legitimate expertise in B2B SaaS metrics and marketplace dynamics, and their partners have been there before. The trade-off is they can be pretty hands-on (some founders love this, others find it overwhelming). They're particularly strong if you're building in Europe and want investors who understand the regulatory landscape and local market dynamics. Less impressive if you're looking for Silicon Valley-style risk appetite or massive checks.

Cipio is the grown-up in the room when European tech companies need to transition from scrappy startup to serious business. They're not chasing the latest AI hype or throwing money at unproven models - they want companies with €10M+ revenue that need capital and operational expertise to scale. The team has serious operational chops (multiple successful exits, board experience) and isn't afraid of complex deals that provide liquidity to early investors while fueling growth. Founders consistently praise their hands-on approach and M&A expertise. The downside? They're not your Series A darling - if you're pre-revenue or looking for patient capital to figure out product-market fit, look elsewhere.

Creandum hits above their weight class thanks to early Spotify and Klarna wins, giving them serious credibility and deal flow. They're genuinely founder-friendly Europeans who understand the unique challenges of building across fragmented European markets. The partners are operationally experienced and don't just write checks - they roll up sleeves. However, they can be quite selective and sometimes overly cautious on newer sectors outside their comfort zone. Their Nordic network is gold, but if you're not planning European expansion, there are probably better fits.

Credo is the real deal in CEE — they've been building the ecosystem there for over a decade and have the track record to prove it. They're genuinely helpful post-investment, especially with international expansion, and their partners actually know how to build companies. The downside? They're hyper-focused on their region, so if you're not CEE-connected or don't fit their geographic thesis, you're probably wasting your time. They move slower than Silicon Valley funds but are way more thoughtful about long-term value creation.

Daphni is a solid if unspectacular European fund that knows deep tech but moves at French speed, not Silicon Valley speed. They're genuinely helpful post-investment with intros and strategic guidance, but don't expect lightning-fast decision making. The partners have real operational chops and won't bullshit you about market realities. They're particularly strong if you're building something technical that needs European market expertise, but might not be your first choice if you need someone who can move fast on a hot round.

Dawn is one of the more operationally-focused European funds that actually delivers on their promises to help with international expansion. Haakon's entrepreneurial credibility opens doors, and they're genuinely useful for European companies trying to crack the US market. They move fast when they want a deal and don't play games with term sheets. The downside? They can be pretty demanding post-investment and expect you to hit aggressive international growth targets. If you're not ready to scale globally quickly, they might not be the right fit.

Molten is the rare publicly-listed VC (FTSE 250) which gives you transparency but also means they're beholden to public market pressures that can create odd incentives. Their track record is solid - they've delivered strong exits like M-Files at 7.4x and Endomag at 3.9x MOIC, consistently hitting or beating their carrying values. They actually deliver on their value-add promises - portfolio companies genuinely praise their enterprise network connections and ability to accelerate sales cycles. The 'patient capital' positioning isn't just marketing - being public means they can hold positions longer than traditional fund cycles. Leadership transition is worth watching - new CEO Ben Wilkinson stepped up from CFO role when Martin Davis left, so jury's still out on strategic direction under new management.

Earlybird is one of Europe's genuine OG funds that's earned its stripes the hard way - they've been around since 1997 and have the exits to prove it. Their track record speaks volumes: early backer of UiPath (Europe's largest IPO ever), N26, and Aleph Alpha. What founders need to know is that this isn't just another check-writer - they genuinely get involved post-investment and have built serious operational expertise over 28 years. The recent restructuring shows they're not afraid to evolve and focus where they can add the most value. However, they're getting bigger and more institutionalized, which means longer decision cycles and more process than scrappy early-stage funds. They're also heavily Germanic in their approach - methodical, thorough, but sometimes slower to move than Silicon Valley-style funds.